Medication Therapy for Early-Onset Neonatal Sepsis is organized by American Association of Critical-Care Nurses (AACN).
Expires: Jul 01, 2020
Contact Hours: 1.00
CERP A: 1.00
Suspected sepsis is a common cause of morbidity and mortality in neonates. In a population-based surveillance study from 2005 to 2008, researchers estimated that 3300 cases of early-onset sepsis (EOS) occur in the United States each year, with 390 of these cases resulting in death. The risk is highest in preterm neonates, which account for 1570 of the 3300 cases and 360 deaths. Despite its prevalence, though, identifying patients with sepsis, determining causative organisms, and establishing a length of treatment remain a challenge for health care practitioners.
• List the organisms most commonly associated with early-onset sepsis in neonates.
• Explain how gestational age can be used to determine hemodynamic goals.
• Discuss the laboratory values that can aid in the diagnosis of early-onset sepsis and the limitations associated with each.
Additional details will be posted as soon as they are available.
Clinical Pharmacology, Neonatal and Perinatology, Pharmacy and Medicine